BACKGROUND Recently, we established paclitaxel-resistant prostate cancer cell lines (PC-3-TxR and DU145-TxR). To determine the mechanisms of paclitaxel resistance in PC-3-TxR cells, we compared the gene expression profiles between PC-3 and PC-3-TxR cells. Our results indicated that expression of the C-terminal tensin like protein (CTEN, tensin 4) gene was down-regulated by 10-fold in PC-3-TxR cells. We investigated the possibility that CTEN overexpression restores paclitaxel sensitivity. METHODS We investigated how knockdown and overexpression of CTEN in androgen-independent cell lines affect paclitaxel sensitivity by colony formation assay and growth inhibition assay. To determine the mechanisms by which CTEN affects paclitaxel sensitiv...
<div><p>p63 is a member of the p53 transcription factor family and a linchpin of epithelial developm...
C-terminal tensin-like (CTEN), also called Tensin4 (TNS4), is the fourth member of the tensin family...
Abstract Background Overcoming drug resistance is cri...
金沢大学附属病院泌尿器科BACKGROUND. Recently, we established paclitaxel-resistant prostate cancer cell lines (PC...
BACKGROUND Although paclitaxel is used for hormone-resistant prostate cancer, relapse definitely oc...
金沢大学医学部附属病院泌尿器科BACKGROUND. Although paclitaxel is used for hormone-resistant prostate cancer, relaps...
Prostate cancer is the leading cause of cancer-related death among men in developed countries. Altho...
p63 is a member of the p53 transcription factor family and a linchpin of epithelial development and ...
Chemotherapy of castration resistant prostate cancer (CRPC) is based on taxane formulations worldwid...
<div><p>Taxane based chemotherapy is the standard of care treatment in castration resistant prostate...
Taxane based chemotherapy is the standard of care treatment in castration resistant prostate cancer ...
Cten (also known as Tensin4) is the fourth member of the Tensin gene family. It lacks the N terminal...
PTTG1 protein, the human securin, has a central role in sister chromatid separation during mitosis, ...
Taxane based chemotherapy is an effective treatment for castration-resistant prostate cancer (CRPC) ...
The C-terminal tensin-like (Cten) gene is a member of the tensin family and is localised at the cyto...
<div><p>p63 is a member of the p53 transcription factor family and a linchpin of epithelial developm...
C-terminal tensin-like (CTEN), also called Tensin4 (TNS4), is the fourth member of the tensin family...
Abstract Background Overcoming drug resistance is cri...
金沢大学附属病院泌尿器科BACKGROUND. Recently, we established paclitaxel-resistant prostate cancer cell lines (PC...
BACKGROUND Although paclitaxel is used for hormone-resistant prostate cancer, relapse definitely oc...
金沢大学医学部附属病院泌尿器科BACKGROUND. Although paclitaxel is used for hormone-resistant prostate cancer, relaps...
Prostate cancer is the leading cause of cancer-related death among men in developed countries. Altho...
p63 is a member of the p53 transcription factor family and a linchpin of epithelial development and ...
Chemotherapy of castration resistant prostate cancer (CRPC) is based on taxane formulations worldwid...
<div><p>Taxane based chemotherapy is the standard of care treatment in castration resistant prostate...
Taxane based chemotherapy is the standard of care treatment in castration resistant prostate cancer ...
Cten (also known as Tensin4) is the fourth member of the Tensin gene family. It lacks the N terminal...
PTTG1 protein, the human securin, has a central role in sister chromatid separation during mitosis, ...
Taxane based chemotherapy is an effective treatment for castration-resistant prostate cancer (CRPC) ...
The C-terminal tensin-like (Cten) gene is a member of the tensin family and is localised at the cyto...
<div><p>p63 is a member of the p53 transcription factor family and a linchpin of epithelial developm...
C-terminal tensin-like (CTEN), also called Tensin4 (TNS4), is the fourth member of the tensin family...
Abstract Background Overcoming drug resistance is cri...